Literature DB >> 26563356

Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.

Victor Wong, Dean Pavlick, Tim Brennan, Roman Yelensky, John Crawford, Jeffrey S Ross, Vincent A Miller, Denise Malicki, Philip J Stephens, Siraj M Ali1, Hyunah Ahn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26563356     DOI: 10.1093/jnci/djv307

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  36 in total

Review 1.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

2.  A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.

Authors:  Ning Zhou; Reinhold Schäfer; Tao Li; Meiyu Fang; Luying Liu
Journal:  BMC Cancer       Date:  2018-08-22       Impact factor: 4.430

3.  Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.

Authors:  Yu-Chien Kao; Christopher D M Fletcher; Rita Alaggio; Leonard Wexler; Lei Zhang; Yun-Shao Sung; Dicle Orhan; Wei-Chin Chang; David Swanson; Brendan C Dickson; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-01       Impact factor: 6.394

Review 4.  New fusion sarcomas: histopathology and clinical significance of selected entities.

Authors:  Markku Miettinen; Anna Felisiak-Golabek; Alejandro Luiña Contreras; John Glod; Rosandra N Kaplan; Jonathan Keith Killian; Jerzy Lasota
Journal:  Hum Pathol       Date:  2019-01-08       Impact factor: 3.466

5.  Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.

Authors:  Pierre Vanden Borre; Alexa B Schrock; Peter M Anderson; John C Morris; Andreas M Heilmann; Oliver Holmes; Kai Wang; Adrienne Johnson; Steven G Waguespack; Sai-Hong Ignatius Ou; Saad Khan; Kar-Ming Fung; Philip J Stephens; Rachel L Erlich; Vincent A Miller; Jeffrey S Ross; Siraj M Ali
Journal:  Oncologist       Date:  2017-02-16

Review 6.  TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Authors:  Shivaani Kummar; Ulrik N Lassen
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

Review 7.  Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand?

Authors:  Susan Jehangir; Jujju J Kurian; Dharshini Selvarajah; Reju J Thomas; Andrew J A Holland
Journal:  Pediatr Surg Int       Date:  2017-08-30       Impact factor: 1.827

8.  Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.

Authors:  Narasimhan P Agaram; Lei Zhang; Yun-Shao Sung; Chun-Liang Chen; Catherine T Chung; Cristina R Antonescu; Christopher Dm Fletcher
Journal:  Am J Surg Pathol       Date:  2016-10       Impact factor: 6.394

9.  Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Andrei S Potapov; Anastasia R Kovrizhina; Vladislava V Matveevskaya; Maxim L Belyanin; Dmitriy N Atochin; Svitlana O Zanoza; Nadiya M Gaidarzhy; Sergiy A Lyakhov; Liliya N Kirpotina; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2018-10-12       Impact factor: 6.514

10.  Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions.

Authors:  Cristina R Antonescu; Brendan C Dickson; David Swanson; Lei Zhang; Yun-Shao Sung; Yu-Chien Kao; Wei-Chin Chang; Leili Ran; Alberto Pappo; Armita Bahrami; Ping Chi; Christopher D Fletcher
Journal:  Am J Surg Pathol       Date:  2019-10       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.